112 related articles for article (PubMed ID: 32652401)
1. Casein nanoparticles as oral delivery carriers of mequindox for the improved bioavailability.
Chen L; Wei J; An M; Zhang L; Lin S; Shu G; Yuan Z; Lin J; Peng G; Liang X; Yin L; Zhang W; Zhao L; Fu H
Colloids Surf B Biointerfaces; 2020 Nov; 195():111221. PubMed ID: 32652401
[TBL] [Abstract][Full Text] [Related]
2. pH-driven entrapment of enrofloxacin in casein-based nanoparticles for the enhancement of oral bioavailability.
Yuan ZX; Deng S; Chen L; Hu Y; Gu J; He L
Food Sci Nutr; 2021 Aug; 9(8):4057-4067. PubMed ID: 34401057
[TBL] [Abstract][Full Text] [Related]
3. Solid self-emulsifying casein carrier for the improvement on the oral bioavailability of simvastatin.
Li H; Sun H; Zhao Y; Wang S; Zhao Y
Int J Biol Macromol; 2024 May; 268(Pt 2):131516. PubMed ID: 38621556
[TBL] [Abstract][Full Text] [Related]
4. Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin.
Peñalva R; Esparza I; Morales-Gracia J; González-Navarro CJ; Larrañeta E; Irache JM
Int J Pharm; 2019 Oct; 570():118652. PubMed ID: 31472219
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
Kenechukwu FC; Dias ML; Ricci-Júnior E
Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
[TBL] [Abstract][Full Text] [Related]
6. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
7. Preparation, Optimization, and Anti-Pulmonary Infection Activity of Casein-Based Chrysin Nanoparticles.
Tang H; Dong L; Xia X; Chen X; Ren M; Shu G; Fu H; Lin J; Zhao L; Zhang L; Cheng G; Wang X; Zhang W
Int J Nanomedicine; 2024; 19():5511-5522. PubMed ID: 38895144
[TBL] [Abstract][Full Text] [Related]
8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
[TBL] [Abstract][Full Text] [Related]
11. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
12. Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles.
Peñalva R; Morales J; González-Navarro CJ; Larrañeta E; Quincoces G; Peñuelas I; Irache JM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231546
[TBL] [Abstract][Full Text] [Related]
13. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
14. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy.
Lu C; Li X; Xia W; Lu S; Luo H; Ye D; Zhang Y; Liu D
Acta Biomater; 2017 Feb; 49():434-443. PubMed ID: 27867110
[TBL] [Abstract][Full Text] [Related]
15. In silico-in vitro-in vivo studies of experimentally designed carvedilol loaded silk fibroin-casein nanoparticles using physiological based pharmacokinetic model.
Kumar S; Singh SK
Int J Biol Macromol; 2017 Mar; 96():403-420. PubMed ID: 28013012
[TBL] [Abstract][Full Text] [Related]
16. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
[TBL] [Abstract][Full Text] [Related]
17. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
19. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
20. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats.
Kalaria DR; Sharma G; Beniwal V; Ravi Kumar MN
Pharm Res; 2009 Mar; 26(3):492-501. PubMed ID: 18998202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
